102 related articles for article (PubMed ID: 11954156)
1. Needlestick injury. Anti-HIV drug branded 'lethal'.
Nurs Times; 2001 Jan 18-24; 97(3):5. PubMed ID: 11954156
[No Abstract] [Full Text] [Related]
2. Most common prescribing error in postexposure prophylaxis of HIV/AIDS.
Mahajan A; Sharma H; Bhagat A; Tandon VR; Sharma R; Sharma S
J Assoc Physicians India; 2007 Mar; 55():246-7. PubMed ID: 17598343
[No Abstract] [Full Text] [Related]
3. Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers.
Sha BE; Proia LA; Kessler HA
JAMA; 2000 Dec; 284(21):2723. PubMed ID: 11105176
[No Abstract] [Full Text] [Related]
4. Post-exposure prophylaxis.
van der Ende ME; Regez RM; Schreij G; van der Meer JT; Danner SA;
Int J STD AIDS; 2002 Dec; 13 Suppl 2():30-4. PubMed ID: 12537723
[TBL] [Abstract][Full Text] [Related]
5. Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers.
Johnson S; Baraboutis JG
JAMA; 2000 Dec; 284(21):2722-3. PubMed ID: 11105175
[No Abstract] [Full Text] [Related]
6. Should patients be compelled to undergo HIV testing after a needlestick injury involving a health care worker?
Ross JJ; Levangie D; Worthington MG
Pharos Alpha Omega Alpha Honor Med Soc; 2006; 69(1):32-6. PubMed ID: 16544462
[No Abstract] [Full Text] [Related]
7. Reports on nevirapine threaten public health.
Lane HC; Folkers GK; Fauci AS
Nat Med; 2005 Mar; 11(3):245. PubMed ID: 15746930
[No Abstract] [Full Text] [Related]
8. Nevirapine should not be prescribed for needlestick injuries.
Gottlieb S
BMJ; 2001 Jan; 322(7279):126. PubMed ID: 11159560
[No Abstract] [Full Text] [Related]
9. US AIDS chief altered report on nevirapine safety risks.
Singer E
Nat Med; 2005 Jan; 11(1):3. PubMed ID: 15635419
[No Abstract] [Full Text] [Related]
10. Nevirapine may promote resistance.
AIDS Patient Care STDS; 2004 Apr; 18(4):249-50. PubMed ID: 15154406
[No Abstract] [Full Text] [Related]
11. [HIV prevention after needlestick injury: preventive possibilities not proven, but likely. Official recommendations are still unavailable].
Schweiger A
Fortschr Med; 1996 Oct; 114(28):16, 18. PubMed ID: 9011527
[No Abstract] [Full Text] [Related]
12. Management of needlestick injuries.
Ferreiro RB; Sepkowitz KA
Clin Obstet Gynecol; 2001 Jun; 44(2):276-88. PubMed ID: 11344992
[No Abstract] [Full Text] [Related]
13. HIV transmission. Allegations raise fears of backlash against AIDS prevention strategy.
Cohen J
Science; 2004 Dec; 306(5705):2168-9. PubMed ID: 15618490
[No Abstract] [Full Text] [Related]
14. Stevens-Johnson syndrome in an HIV-infected patient.
Blitz M; Spivack E; Kerpel SM; Freedman PD
AIDS Read; 1999; 9(3):184-5, 190. PubMed ID: 12728904
[TBL] [Abstract][Full Text] [Related]
15. Liver transplantation for fulminant hepatitis related to nevirapine therapy.
Buyse S; Vibert E; Sebagh M; Antonini T; Ichai P; Castaing D; Samuel D; Duclos-Vallée JC
Liver Transpl; 2006 Dec; 12(12):1880-2. PubMed ID: 17133571
[TBL] [Abstract][Full Text] [Related]
16. Mother to child transmission of HIV.
Volmink J
Clin Evid; 2002 Dec; (8):780-7. PubMed ID: 12603913
[No Abstract] [Full Text] [Related]
17. Call for mandatory HIV accident rules.
Porter R
Nurs Times; 1997 Jul 9-15; 93(28):10. PubMed ID: 9277197
[No Abstract] [Full Text] [Related]
18. Nevirapine-associated rash in a Jamaican child with HIV/AIDS.
Steel-Duncan JC; Pierre R; Gabay L; Christie CD
West Indian Med J; 2004 Oct; 53(5):356-8. PubMed ID: 15675504
[TBL] [Abstract][Full Text] [Related]
19. Mother to child transmission of HIV.
Volmink J
Clin Evid; 2002 Jun; (7):709-16. PubMed ID: 12230698
[No Abstract] [Full Text] [Related]
20. HLA-Cw8 primarily associated with hypersensitivity to nevirapine.
Gatanaga H; Yazaki H; Tanuma J; Honda M; Genka I; Teruya K; Tachikawa N; Kikuchi Y; Oka S
AIDS; 2007 Jan; 21(2):264-5. PubMed ID: 17197830
[No Abstract] [Full Text] [Related]
[Next] [New Search]
